Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04819581 · ClinicalTrials.gov registry record · Phase 1

Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects

A Phase 1 study of Healthy, sponsored by Scilex Pharmaceuticals.

Completed
Registry status
Phase 1
Development phase
15
Enrollment target
1
Study location

NCT04819581 is a Phase 1 study of Healthy that has completed, run by Scilex Pharmaceuticals. The registered enrollment target is 15 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04819581, a Phase 1 study of Healthy, has completed, sponsored by Scilex Pharmaceuticals.

COMPLETED
Registry status
Phase 1
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical system following one, two, or three topical system applications and compare to the pharmacokinetics of ZTlido.

Conditions Studied

Healthy

Interventions

  • DRUG SP-103
  • DRUG ZTlido

Study Locations (1)

Minnesota

  • AXIS Clinicals - Dilworth

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-08-03
Est. Completion 2019-08-27
Phase Phase 1

Sponsor

Scilex Pharmaceuticals

7 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04819581

The ClinicalTrials.gov registry entry for NCT04819581 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Scilex Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which SP-103 is the first listed.

NCT04819581 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04819581 about?

NCT04819581 is a clinical study titled "Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects". This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical system following one, two, or three topical system applications and compare to the pharmacokinetics of ZTlido.

What is the current status of trial NCT04819581?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2019-08-03. Estimated completion is 2019-08-27.

What conditions does trial NCT04819581 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04819581?

The interventions under investigation include: SP-103 (DRUG), ZTlido (DRUG).

Who is sponsoring clinical trial NCT04819581?

This trial is sponsored by Scilex Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04819581 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.